Inhibition of Rab1B Impairs Trafficking and Maturation of SARS-CoV-2 Spike Protein

Viruses. 2023 Mar 24;15(4):824. doi: 10.3390/v15040824.

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) utilizes cellular trafficking pathways to process its structural proteins and move them to the site of assembly. Nevertheless, the exact process of assembly and subcellular trafficking of SARS-CoV-2 proteins remains largely unknown. Here, we have identified and characterized Rab1B as an important host factor for the trafficking and maturation of the spike protein (S) after synthesis at the endoplasmic reticulum (ER). Using confocal microscopy, we showed that S and Rab1B substantially colocalized in compartments of the early secretory pathway. Co-expression of dominant-negative (DN) Rab1B N121I leads to an aberrant distribution of S into perinuclear spots after ectopic expression and in SARS-CoV-2-infected cells caused by either structural rearrangement of the ERGIC or Golgi or missing interaction between Rab1B and S. Western blot analyses revealed a complete loss of the mature, cleaved S2 subunit in cell lysates and culture supernatants upon co-expression of DN Rab1B N121I. In sum, our studies indicate that Rab1B is an important regulator of trafficking and maturation of SARS-CoV-2 S, which not only improves our understanding of the coronavirus replication cycle but also may have implications for the development of antiviral strategies.

Keywords: Rab1B; SARS-CoV-2; spike protein; virus–host cell interactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / metabolism
  • Golgi Apparatus / metabolism
  • Humans
  • SARS-CoV-2 / metabolism
  • Spike Glycoprotein, Coronavirus* / metabolism
  • rab1 GTP-Binding Proteins / analysis
  • rab1 GTP-Binding Proteins / genetics
  • rab1 GTP-Binding Proteins / metabolism

Substances

  • spike protein, SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • Rab1B protein, human
  • rab1 GTP-Binding Proteins

Grants and funding

This research was funded by the German Center of Infection Research (DZIF, TTU 01.711), project number 8033701711, by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—KFO 309, project number 284237345 (to SB), by the Pandemie Netzwerk Hessen (to SB and CR) and Coropan (LOEWE; to NB and SB). Open Access funding provided by the Open Acess Publishing Fund of Philipps-Universität Marburg with support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).